Pharming to present at UBS Global Life Sciences Conference
(Thomson Reuters ONE) - Leiden, The Netherlands, September 17, 2009. Biotech companyPharming Group NV ("Pharming") (NYSE Euronext: PHARM) today announcedthat it will present at the UBS Global Life Sciences Conference(September 21-23, 2009) in New York.Sijmen de Vries, Chief Executive Officer of Pharming, will present anupdate on the Company and its business on Monday, September 21 at2:00 pm Eastern Time (8:00 pm Central European Time). The live audiowebcast can be accessed via the UBS website. The presentation will beavailable on Pharming's website after the meeting.The conference attendees include institutional investors from theUnited States, Europe and Asia-Pacific. For further information onthe UBS Global Life Sciences Conference, please visitwww.ibb.ubs.com.About Pharming Group NVPharming Group NV is developing innovative products for the treatmentof genetic disorders, ageing diseases, specialty products forsurgical indications, intermediates for various applications andnutritional products. Pharming has two products in late stagedevelopment - Rhucin® for Hereditary Angioedema and human Lactoferrinfor use in food products and one product in early stage clinicaldevelopment - Prodarsan® for Cockayne Syndrome. The advancedtechnologies of the Company include innovative platforms for theproduction of protein therapeutics, technology and processes for thepurification and formulation of these products, as well as technologyin the field of DNA repair (via DNage). Additional information isavailable on the Pharming website, http://www.pharming.com.This press release contains forward looking statements that involveknown and unknown risks, uncertainties and other factors, which maycause the actual results, performance or achievements of the Companyto be materially different from the results, performance orachievements expressed or implied by these forward lookingstatements.Contact:Ms. Marjolein van Helmond, Pharming Group NV, T: +31 (0)71 52 47 431or +31 (0)6 109 299 54http://hugin.info/132866/R/1342081/321125.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 17.09.2009 - 18:00 Uhr
Sprache: Deutsch
News-ID 5942
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 255 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharming to present at UBS Global Life Sciences Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Pharming Group N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
